MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Dispersible tablet, therefore unsuitable.

Provenance

This compatibility recommendation is derived from Madopar 100mg/25mg dispersible tablets (Roche Products Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Madopar 200mg/50mg capsules (Roche Products Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd) and Madopar 50mg/12.5mg capsules (Roche Products Ltd).

Stability Notes

Dispersible tablet, therefore unsuitable.

Provenance

This compatibility recommendation is derived from Madopar 50mg/12.5mg dispersible tablets (Roche Products Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Madopar CR capsules (Roche Products Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Madopar CR capsules (Roche Products Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.